FDA says Ozempic, Wegovy are not in short supply anymore, which could impact prices
The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply. CBS News New York reporter Ali Bauman reports on whether the supply change could lead to consumers paying more.
Weight-loss drugs and prescription medications for ADHD are among the latest items being offered for sale by dealers, an ...
Until now, it was believed that some drugs used worldwide were the best alternative against certain diseases. However, ...
A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...
The resolution could potentially restrict how telehealth programs offer cheaper versions known as compounded drugs ...
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...
A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback